Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Cardiology | Hematology | Journal

Back to Journal Articles

Device Found as Effective as Heparin for Clot Prevention

Last Updated: April 27, 2010.

 

And fewer major bleeding events after hip arthroplasty seen with mobile compression device

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
The use of a mobile compression device for the prevention of thromboembolic disease after total hip arthroplasty is likely just as effective as low-molecular-weight heparin treatment but safer, according to a study in the March issue of the Journal of Bone & Joint Surgery.

TUESDAY, April 27 (HealthDay News) -- The use of a mobile compression device for the prevention of thromboembolic disease after total hip arthroplasty is likely just as effective as low-molecular-weight heparin treatment but safer, according to a study in the March issue of the Journal of Bone & Joint Surgery.

Clifford W. Colwell Jr., M.D., of Scripps Clinic in La Jolla, Calif., and colleagues randomized 410 patients (414 hips) who had undergone a total hip arthroplasty to receive prophylaxis with use of a mobile compression device that began intraoperatively and continued for 10 days, or low-molecular-weight heparin, started 12 to 24 hours post-surgery, for 10 days.

The researchers found that the rate of distal deep venous thrombosis was 3 percent in both groups, while the rate of proximal deep venous thrombosis was 1 percent in patients who received heparin compared with 2 percent of patients who used the mobile compression device. The rate of pulmonary embolism was 1 percent in both groups. However, the rate of major bleeding events was significantly lower among patients who received the mobile compression device compared to those who were prescribed low-molecular-weight heparin (0 versus 6 percent).

"When compared with low-molecular-weight heparin, use of the mobile compression device for prophylaxis against venous thromboembolic events following total hip arthroplasty resulted in a significant decrease in major bleeding events," the authors write.

One or more of the authors disclosed financial ties to Medical Compression Systems, and one or more of the authors disclosed financial ties to Sanofi-Aventis and Zimmer.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2010 HealthDay. All rights reserved.


Previous: Women With PCOS Exhibit Different Insulin Reactions Next: Nearly Half of Adults Have at Least One Cardiac Risk Factor

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.